Predictions
Poxel S.A.
Start price
Target price
Perf. (%)
€4.07
15.02.22
15.02.22
€5.00
15.03.22
15.03.22
-25.36%
20.02.22
20.02.22
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€3.24
10.02.22
10.02.22
€3.80
10.02.23
10.02.23
-4.81%
11.02.23
11.02.23
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€15.03
05.02.22
05.02.22
€20.00
05.02.23
05.02.23
-57.41%
06.02.23
06.02.23
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
Innate Pharma
Start price
Target price
Perf. (%)
€3.51
01.02.22
01.02.22
€4.15
01.02.23
01.02.23
-7.69%
10.02.22
10.02.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€15.90
23.01.22
23.01.22
-
23.01.23
23.01.23
-5.47%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Innate Pharma
Start price
Target price
Perf. (%)
€4.12
10.01.22
10.01.22
-
10.01.23
10.01.23
-14.85%
01.02.22
01.02.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€19.03
04.01.22
04.01.22
-
04.01.23
04.01.23
-7.46%
07.01.22
07.01.22
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€24.64
16.12.21
16.12.21
€33.00
31.12.23
31.12.23
-67.02%
07.09.22
07.09.22
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€23.36
12.12.21
12.12.21
-
12.12.22
12.12.22
8.73%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€23.36
11.12.21
11.12.21
€30.00
11.12.22
11.12.22
8.73%
25.12.21
25.12.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Abivax S.A.
Start price
Target price
Perf. (%)
€25.50
01.12.21
01.12.21
€28.00
01.12.22
01.12.22
-31.92%
20.05.22
20.05.22
Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Valneva SE
Start price
Target price
Perf. (%)
€29.96
30.11.21
30.11.21
€35.00
30.11.22
30.11.22
-66.46%
12.08.22
12.08.22
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€28.32
29.11.21
29.11.21
-
29.11.22
29.11.22
-65.32%
21.07.22
21.07.22
Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€5.24
27.11.21
27.11.21
€8.00
27.11.22
27.11.22
-47.90%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Onxeo S.A.
Start price
Target price
Perf. (%)
€0.41
27.11.21
27.11.21
€0.60
27.11.22
27.11.22
-56.65%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€28.30
27.11.21
27.11.21
€28.00
27.11.22
27.11.22
-44.88%
30.03.22
30.03.22
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Boiron S.A.
Start price
Target price
Perf. (%)
€38.05
26.11.21
26.11.21
-
26.11.22
26.11.22
18.79%
27.11.22
27.11.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€24.38
25.11.21
25.11.21
€21.00
25.11.22
25.11.22
6.64%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Poxel S.A.
Start price
Target price
Perf. (%)
€5.37
24.11.21
24.11.21
€6.00
24.11.22
24.11.22
-24.21%
15.02.22
15.02.22
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.24
19.11.21
19.11.21
€2.60
19.11.22
19.11.22
-69.80%
20.11.22
20.11.22
Could be worthwhile Investment >10% per year
AB Science S.A.
Start price
Target price
Perf. (%)
€12.40
19.11.21
19.11.21
€13.60
19.11.22
19.11.22
-34.44%
20.11.22
20.11.22
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.24
17.11.21
17.11.21
€1.80
17.11.22
17.11.22
0.00%
19.11.21
19.11.21
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€21.24
15.11.21
15.11.21
€25.00
15.11.22
15.11.22
33.24%
27.11.21
27.11.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Nanobiotix
Start price
Target price
Perf. (%)
€8.51
11.11.21
11.11.21
€10.00
11.11.22
11.11.22
-53.17%
12.11.22
12.11.22
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.19
11.11.21
11.11.21
-
11.11.22
11.11.22
2.28%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year